Holen Sie sich die Stockscreener-App
99.84
0.26%
-0.26
Handel nachbörslich:
99.77
-0.07
-0.07%
Schlusskurs vom Vortag:
$100.10
Offen:
$100.1
24-Stunden-Volumen:
40,569
Relative Volume:
0.51
Marktkapitalisierung:
$1.27B
Einnahmen:
$69.48M
Nettoeinkommen (Verlust:
$18.64M
KGV:
68.38
EPS:
1.46
Netto-Cashflow:
$13.01M
1W Leistung:
-3.05%
1M Leistung:
+2.45%
6M Leistung:
+77.27%
1J Leistung:
+66.59%
1-Tages-Spanne:
$96.46
$101.32
1-Wochen-Bereich:
$96.46
$104.93
52-Wochen-Spanne:
$47.48
$104.93
Iradimed Corp Stock (IRMD) Company Profile
Firmenname
Iradimed Corp
Sektor
Branche
Telefon
(407) 677-8022
Adresse
12705 INGENUITY DRIVE, ORLANDO
Vergleichen Sie IRMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
99.84 | 1.27B | 69.48M | 18.64M | 13.01M | 1.46 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-04-12 | Eingeleitet | Lake Street | Buy |
| 2017-10-31 | Fortgesetzt | ROTH Capital | Buy |
| 2016-10-05 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-11-02 | Bestätigt | ROTH Capital | Buy |
| 2015-07-30 | Bestätigt | ROTH Capital | Buy |
| 2015-06-16 | Bestätigt | ROTH Capital | Buy |
| 2015-01-12 | Bestätigt | ROTH Capital | Buy |
| 2014-12-23 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Iradimed Corp Aktie (IRMD) Neueste Nachrichten
IRADIMED Corp (NASDAQ:IRMD) Emerges as a Top Quality Stock from the Caviar Cruise Screen - Chartmill
IRADIMED CORPORATION's (NASDAQ:IRMD) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo Finance
Iradimed stock hits all-time high of 104.67 USD - Investing.com
Insider Unloading: Roger E Susi Sells $509K Worth Of iRadimed Shares - Benzinga
How Record Q3 Results And FDA-Cleared MRI Pump Launch At IRADIMED (IRMD) Has Changed Its Investment Story - Sahm
Insider Selling: iRadimed (NASDAQ:IRMD) CEO Sells 5,000 Shares of Stock - MarketBeat
iRadimed (NASDAQ:IRMD) Hits New 52-Week HighStill a Buy? - MarketBeat
iRadimed Corporation (NASDAQ:IRMD) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
iRadimed Corporation (NASDAQ:IRMD) Given Average Rating of “Moderate Buy” by Analysts - Defense World
iRadimed Corporation (NASDAQ:IRMD) Short Interest Update - MarketBeat
IRadimed Corporation (IRMD): Accelerating with Solid Capital Return - Yahoo Finance
iRadimed (NASDAQ:IRMD) Reaches New 52-Week HighHere's Why - MarketBeat
Iradimed stock hits all-time high at 100.55 USD - Investing.com
CEO Of iRadimed Makes $487K Sale - Benzinga
Iradimed CEO Susi sells $487k in shares By Investing.com - Investing.com Australia
Iradimed CEO Susi sells $487k in shares - Investing.com
Iradimed Insider Sold Shares Worth $487,231, According to a Recent SEC Filing - marketscreener.com
Will IRADIMED CORPORATION stock maintain momentum in 2025 - Улправда
Can IRADIMED CORPORATION stock beat market expectations this quarter2025 Retail Activity & Risk Managed Investment Entry Signals - Улправда
iRadimed (NASDAQ:IRMD) Reaches New 1-Year HighWhat's Next? - MarketBeat
Iradimed Co stock hits all-time high at 99.72 USD - Investing.com India
Iradimed Co stock hits all-time high at 99.72 USD By Investing.com - Investing.com Canada
Insider Unloading: Roger E Susi Sells $488K Worth Of iRadimed Shares - Benzinga
iRadimed (NASDAQ:IRMD) CEO Roger Susi Sells 5,000 Shares - MarketBeat
Copeland Capital Management LLC Has $30.85 Million Holdings in iRadimed Corporation $IRMD - MarketBeat
iRadimed (NASDAQ:IRMD) Hits New 12-Month HighStill a Buy? - MarketBeat
Rice Hall James & Associates LLC Reduces Position in iRadimed Corporation $IRMD - MarketBeat
iRadimed Corporation (NASDAQ:IRMD) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Will IRADIMED CORPORATION stock outperform value stocksFundamental Strength Indicators & Minimal Capital Growth Ideas - Bollywood Helpline
IRADIMED's (NASDAQ:IRMD) investors will be pleased with their incredible 352% return over the last five years - Yahoo Finance
IRMD SEC FilingsIradimed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Insider Decision: Roger E Susi Offloads $483K Worth Of iRadimed Stock - Benzinga
iRadimed (NASDAQ:IRMD) CEO Sells 5,000 Shares - MarketBeat
Iradimed stock reaches all-time high at 98.24 USD By Investing.com - Investing.com South Africa
Iradimed stock reaches all-time high at 98.24 USD - Investing.com
Is IRADIMED’s US$0.50 Special Dividend Reshaping the Investment Case for IRMD? - simplywall.st
Is IRADIMED CORPORATION stock a dividend growth opportunityJuly 2025 Volume & Weekly High Momentum Picks - Улправда
What hedge fund activity signals for IRADIMED CORPORATION stockJuly 2025 Trends & Daily Stock Trend Reports - Улправда
Iradimed (IRMD) CEO and 10% owner Roger Susi discloses Rule 10b5-1 stock sales - Stock Titan
IRADIMED (IRMD): Assessing Valuation After Strong Multi‑Year Share Price Gains - simplywall.st
What Makes IRADIMED CORPORATION (IRMD) a Compelling Opportunity? - Yahoo Finance
Iradimed (IRMD) director receives 1,026 RSUs under 2023 equity plan grant - Stock Titan
Iradimed (NASDAQ: IRMD) director receives 1,026 restricted stock units - Stock Titan
Iradimed (IRMD) director reports 1,026 restricted stock unit award - Stock Titan
Ranger Investment Management L.P. Increases Holdings in iRadimed Corporation $IRMD - MarketBeat
John Glenn Sells 15,000 Shares of iRadimed (NASDAQ:IRMD) Stock - Defense World
iRadimed (NASDAQ:IRMD) CFO John Glenn Sells 15,000 Shares - MarketBeat
Officer Chiprin Acquires 687 Of iRadimed Corp [IRMD] - TradingView — Track All Markets
Iradimed (NASDAQ: IRMD) officer discloses RSU award and tax withholding - Stock Titan
Iradimed (IRMD) director reports RSU vesting and 905 new shares - Stock Titan
Iradimed (IRMD) director discloses 905-share restricted stock unit conversion - Stock Titan
Finanzdaten der Iradimed Corp-Aktie (IRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):